Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Right To Try topic
No spam. Unsubscribe anytime.
Committee pauses further action on 'right to try' bill pending related provisions and information
Summary
Members discussed House Bill 701 (right-to-try) and related measures, including the possibility of attaching a separate pharmacy-related bill as a committee amendment; senators expressed reservations and the committee agreed to hold the bill pending additional answers and to await the fate of related senate measures.
The Judiciary Committee discussed House Bill 701, described in committee as a “right-to-try” measure. Several members said they had outstanding questions and requested additional information before voting on the bill.
One senator said questions he thought were answered the prior evening had resurfaced that morning, and another suggested the committee could consider attaching a previously passed Senate bill (identified in discussion as S.B. 250, concerning pharmacist administration of long-acting injectables) as a committee amendment to HB 701. Committee members debated whether to pass the bill and later amend it on the floor, or to hold the bill in committee while they confirm the status of the related Senate bill and gather answers to outstanding questions.
Members expressed mixed views: some favored moving forward quickly, while others said they preferred to hold the bill to resolve outstanding drafting and policy links to the pharmacy-related measure. The committee recessed to permit follow-up work by staff and to consult with legislative counsel. At the end of the discussion, several members indicated a preference to hold HB 701 until more information is available and until related Senate action is clear; they noted they had until the next week to resolve the timing issue.
The transcript records no final roll-call vote on the underlying bill during this segment; the committee left the item pending further information.
